AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

OTCMKTS:BRTXBioRestorative Therapies Stock Price, Forecast & News

$0.0001
0.00 (0.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.91
Volume1.60 million shs
Average Volume65.13 million shs
Market Capitalization$163,920.00
P/E RatioN/A
Dividend YieldN/A
Beta1
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells for the treatment of disc/spine disease and metabolic disorders. The company's lead cell therapy candidate is the BRTX-100, which focuses on providing non-surgical treatment for protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. It also develops the ThermoStem program, a pre-clinical program for the treatment of metabolic diseases, such as type 2 diabetes, obesity, hypertension, and other metabolic disorders, as well as cardiac deficiencies. In addition, the company provides curved needle device, a needle system with a curved inner cannula that allows access to difficult-to-locate regions for the delivery or removal of fluids and other substances. Further, it offers skin care products under the Stem Pearls brand name. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and a research agreement with Pfizer, Inc. and the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is headquartered in Melville, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BRTX
CUSIPN/A
CIKN/A
Phone631-760-8100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$110,000.00
Book Value($0.68) per share

Profitability

Net Income$-12,520,000.00
Net Margins-13,124.41%

Miscellaneous

Employees8
Outstanding Shares1,639,200,000
Market Cap$163,920.00
Next Earnings DateN/A
OptionableNot Optionable

Receive BRTX News and Ratings via Email

Sign-up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter.

BioRestorative Therapies (OTCMKTS:BRTX) Frequently Asked Questions

How has BioRestorative Therapies' stock been impacted by COVID-19 (Coronavirus)?

BioRestorative Therapies' stock was trading at $0.0003 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BRTX shares have decreased by 66.7% and is now trading at $0.0001. View which stocks have been most impacted by Coronavirus.

Has BioRestorative Therapies been receiving favorable news coverage?

News stories about BRTX stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BioRestorative Therapies earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutBioRestorative Therapies.

Who are some of BioRestorative Therapies' key competitors?

What other stocks do shareholders of BioRestorative Therapies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioRestorative Therapies investors own include Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX), Pharmacyte Biotech (PMCB), Sierra Oncology (SRRA), Ibio (IBIO), Actinium Pharmaceuticals (ATNM), Inpixon (INPX), SANUWAVE Health (SNWV), Kopin (KOPN) and Onconova Therapeutics (ONTX).

Who are BioRestorative Therapies' key executives?

BioRestorative Therapies' management team includes the following people:
  • Mr. Mark R. Weinreb, Chairman, CEO & Pres (Age 66)
  • Mr. Robert Paccasassi, VP of Quality & Compliance (Age 50)
  • Ms. Mandy D. Clyde, VP of Operations & Sec. (Age 37)
  • Dr. Wayne J. Olan, Clinical Director of Regenerative & Spine Program and Member of Scientific Advisory Board
  • Mr. Lance Alstodt, Exec. VP & Chief Strategy Officer (Age 48)

What is BioRestorative Therapies' stock symbol?

BioRestorative Therapies trades on the OTCMKTS under the ticker symbol "BRTX."

How do I buy shares of BioRestorative Therapies?

Shares of BRTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioRestorative Therapies' stock price today?

One share of BRTX stock can currently be purchased for approximately $0.00.

How big of a company is BioRestorative Therapies?

BioRestorative Therapies has a market capitalization of $163,920.00 and generates $110,000.00 in revenue each year. BioRestorative Therapies employs 8 workers across the globe.

What is BioRestorative Therapies' official website?

The official website for BioRestorative Therapies is www.biorestorative.com.

How can I contact BioRestorative Therapies?

BioRestorative Therapies' mailing address is 40 MARCUS DRIVE, MELVILLE NY, 11747. The company can be reached via phone at 631-760-8100 or via email at [email protected]

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.